|
FDMT
|
4D Molecular Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
EVLO
|
Evelo Biosciences, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
0.02%
|
US
|
NASDAQ
|
|
CMRX
|
Chimerix, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
CLVS
|
Clovis Oncology, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
CBAY
|
CymaBay Therapeutics Inc.
|
0.02%
|
US
|
NASDAQ
|
|
BMEA
|
Biomea Fusion, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
AVDL
|
Avadel Pharmaceuticals plc
|
0.02%
|
US
|
NASDAQ
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
ANNX
|
Annexon, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
ALVR
|
AlloVir, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
ALPN
|
Alpine Immune Sciences, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
ADAP
|
Adaptimmune Therapeutics plc
|
0.02%
|
US
|
NASDAQ
|
|
ACIU
|
AC Immune SA
|
0.02%
|
US
|
NASDAQ
|
|
ABSI
|
Absci Corporation
|
0.02%
|
US
|
NASDAQ
|
|
ABOS
|
Acumen Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
WVE
|
WAVE Life Sciences Ltd.
|
0.02%
|
US
|
NASDAQ
|
|
VRCA
|
Verrica Pharmaceuticals Inc.
|
0.01%
|
US
|
NASDAQ
|
|
VIRX
|
Viracta Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|